ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,365, issued on Dec. 23, was assigned to INSTYTUT BIOLOGII DOSWIADCZALNEJ IM. MARCELEGO NENCKIEGO POLSKA AKADEMIA NAUK (Warsaw, Poland) and UNIWERSYTET WARSZAWSKI (Warsaw, Poland).
"Use of marimastat for preventing and/or treating epileptogenesis" was invented by Leszek Kaczmarek (Komorow, Poland), Barbara Pijet-Binkiewicz (Warsaw, Poland), Anna Konopka (Warsaw, Poland) and Emilia Rejmak-Kozicka (Warsaw, Poland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to use of marimastat or a pharmaceutically acceptable salt, solvate or polymorph thereof in preventing or treating epileptogenesis in a subject that suffered a bra...